Hunting, trapping, and wilderness-related work

Clinics in Occupational and Environmental Medicine

Volumn 2, Issue 3, 2002, Pages 651-661

  Guidotti, Tee L ^a   Naidoo, Komali ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN;

ANIMAL HUNTING; ANIMAL TRAPPING; BITE; CARCASS; FLEA; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; LEPTOSPIROSIS; MEAT; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; RABIES; RAT BITE FEVER; REVIEW; TICK BORNE DISEASE; WILDLIFE;

EID: 0042921524     PISSN: 15260046     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-0046(03)00013-X     Document Type: Review

References (71)

1. Fritz CL, Fulhorst CF, Enge B, Winthrop KL, Glaser CA, Vugia DJ. Exposure to rodents and rodent-borne viruses among persons with elevated occupational risk. J Occup Environ Med 2002;44(10):962-7.
2. Frank SA, Jeffrey JS. The probability of severe disease in zoonotic and commensal infections. Proc R Soc Lond B Biol Sci 2001;268:53-60.
3. Larkin M. Hunting and logging linked to emerging infectious diseases. Lancet 2000;356:1173.
4. Zeitz PS, Graber JM, Voorhees RA, et al. Assessment of occupational risk for Hantavirus infection in Arizona and New Mexico. J Occp Environ Med 1997;39:463-7.
5. Lehane L, Rwalin GT. Tropically acquired bacterial zoonoses from fish: a review. Med J Aust 2000;173:256-9.
6. Otten EJ. Hunting injuries. In: Auerbach PS, editor. wilderness medicine: management of wilderness and environmental emergencies. 3rd edition. St Louis: Mosby; 1995. p. 361-3.
7. Huang C, Campbell WP, Means R, Ackman DM. Hantavirus S RNA sequence from a fatal case of HPS in New York. J Med Virol 1996;50:5-8.
8. Lee HW, Lee PW, Johnson KM. Isolation of the etiologic agent of Korean hemorrhagic fever. J Inf Dis 1978;137:298-308.
9. Schmaljohn C, Hasty S, Dalrymple J, LeDuc J, Lee HW, von Bonsdorff C, et al. Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science 1985; 227:1041-4.
10. Chu YK, Rossi C, LeDuc JW, Lee HW, Schmaljohn CS, Dalrymple JM. Serological relationships among viruses in the Hantavirus genus, Family Bunyaviridae. Virology 1994;198:196-204.
11. Xiao SY, LeDuc JM, Chu YK, Schmaljohn CS. Phylogenetic analysis of virus isolates in genus Hantavirus, Family Bunyaviridae. Virology 1994;198:205-17.
12. Simmons JH, Riley LK. Hantaviruses: an overview. Comp Med 2002;52:97-110.
13. McKee KT, LeDuc JW, Peters CJ. Hantaviruses. In: Belshe RD, editor. Textbook of human virology. 2nd edition. St. Louis: Mosby Year Book; 1991. p. 615-32.
14. Childs JE, Ksiazek TG, Spiropoulou CF, Krebs JW, Morzunov S, Maupin GO, et al. Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservior for a new hantavirus in the southwestern United States. J Infect Dis 1994;169:1271-80.
15. Morzunov SP, Feldman H, Spiropoulou CF, Semenova VA, Rollin PE, Ksiazek TG, et al. A newly recognized virus associated with a fatal case of Hantavirus Pulmonary Syndrome in Louisiana. J Virol 1995;69:1980-3.
16. Rawlings JA, Torrez-Martinez N, Neill SU, Moore GM, Hicks BN, Pichuantes S, et al. Cocirculation of multiple hantaviruses in Texas, with characterization of the small (S) genome of a previously undescribed virus of Cotton Rats (Sigmdon hispidus). Am J Trop Med Hyg 1996;55: 672-9.
17. Rollin PE, Ksiazek TG, Elliott LH, Ravkov EV, Martin ML, Morzunov S, et al. Isolation of Black Creek Canal Virus, a new hantavirus from Sigmodon hispidus in Florida. J Med Virol 1995;46:35-9.
18. Torrez-Martinez N, Hjelle B. Enzootic of Bayou hantavirus in rice rats (Oryzomys palustris) in 1983. Lancet 1995;346:780-1.
19. Peters CJ. Ebola and Hantaviruses. FEMS Immunol Med Microbiol 1997;18:281-9.
20. Mills JN, Childs JE. Ecologic studies of rodent reservoirs: their relevance for human health. Emerging Infect Dis 1998;4:529-37.
21. Shope RE. A midcourse assessment of Hantavirus Pulmonary Syndrome. Emerging Infect Dis 1999;5:172-4.
22. Epstein PR. Climate, ecology, and human health. Consequences 1997;3:3-19.
23. Avsic-Zupanc T, Xiao SY, Stojanovic R, Gligic A, van der Groen G, LeDuc JW. Characterization of Dobrava virus: a hantavirus from Slovenia, Yugoslavia. J Med Virol 1992;38:132-7.
24. Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, Feldman H, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993;262:914-7.
25. Hjelle B, Jenison S, Torrez-Martinez N, Yamada T, Nolte K, Zumwalt R, et al. A novel hantavirus associated with an outbreak of fatal respiratory disease in the Southwestern United States: evolutionary relationships to known hantaviruses. J Virol 1994;68:592-6.
26. Warner GS. Hantavirus illness in humans: review and update. South Med J 1996;89(3):264-71.
27. Whitaker Jr. JO. The Audubon Society field guide to North American mammals. New York: Alfred A. Knopf; 1980.
28. Kitsutani PT, Denton RW, Fritz CL, Murray RA, Todd RL, Pape WJ, et al. Acute Sin Nombre hantavirus infection without pulmonary syndrome, United States. Emerging Infect Dis 1999;5: 701-5.
29. Simonsen L, Dalton MJ, Breiman RF, Hennessy T, Umland ET, Sewell CM. Evaluation of the magnitude of the 1993 hantavirus outbreak in the Southwestern United States. J Infect Di 1995; 172:729-33.
30. Pflieger AK, Khan AS. Hantaviruses: Four years after four corners. Hosp Pract 1997;32:93-108.
31. Duchin JS, Koster FT, Peters CJ, Simpson GL, Tempest B, Zaki SR, et al. Hantavirus Pulmonary Syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med 1994;330:949-55.
32. Khan AS, Khabbaz RF, Armstrong LR, Holman RC, Bauer SP, Graber J, et al. Hantavirus Pulmonary Syndrome: the first 100 US cases. J Infect Dis 1996;173:1297-303.
33. Hallin GW, Simpson SQ, Crowell RE, James DS, Koster FT, Mertz GJ, et al. Cardiopulmonary manifestations of Hantavirus Pulmonary Syndrome. Crit Care Med 1996;24:252-8.
34. Drebot MA, Artsob H, Werker D. Hantavirus pulmonary syndrome in Canada, 1989-1999. Can Commun Dis Rep 2000;26:65-9.
35. Xu ZY, Tang YW, Kan LY, Tsai TF. Cats - source of protection or infection? A case-control study of hemorrhagic fever with renal syndrome. Am J Epidemiol 1987;126:942-8.
36. Zeitz PS, Butler JC, Check JE, et al. A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States. J Infect Dis 1995;171:864-70.
37. Chisolm S. Common questions about Hantavirus Pulmonary Syndrome. Am J Nurs 1997;97:68-70.
38. Wells FM, Sosa ES, Yadon ZE, Enria D, Padula P, Pini N, et al. An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Emerg Infect Dis 1997;3:171-4.
39. Mills JN, Yates TL, Ksiazek TG, Peters CJ, Childs JE. Long-term studies of hantavirus reservoir populations in the Southwestern United States: rationale, potential, and methods. Emerg Infect Dis 1999;5:95-101.
40. Crowcroft NS, Infuso A, Le Guenno B, Van Loock F, Clement J. Risk factors for human hantavirus infection: Franco-Belgian collaborative case-control study during 1995-6 epidemic. BMJ 1999;318:1737-8.
41. Health Canada. Hantavirus Pulmonary Syndrome in Canada. Can Commun Dis Rep 1995;21:77-80.
42. Werker DH, Artsob H. Of mice and mostly men - hantavirus pulmonary syndrome. CMAJ 1998;158:912-5.
43. Werker DH, Artsob H, Dick D, Spika J. Hantavirus pulmonary syndrome: a Canadian perspective [abstract]. Presented at the Fourth International Conference on HERS and Hantaviruses. Oral Presentations. Atlanta, March 5-7, 1998.
44. Mills JN, Corneli A, Young JC, Garrison EL, Khan AS, Ksiazek TG. Hantavirus pulmonary syndrome - United States: updated recommendations for risk reduction. MMWR Morb Mortal Wkly Rep 2002;51:1-12.
45. Callaham ML. Bites and injuries inflicted by mammals. In: Auerbach PS, editor. Wilderness medicine: management of wilderness and environmental emergencies. 3rd edition. St. Louis: Mosby; 1995. p. 956.
46. Telford III SR, Dawson JE, Katavolos P, Warner CK, Kolbert CP, Persing DH. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc Natl Acad Sci U S A 1996;93:6209-14.
47. Zizi M, Heyman P, Vandenvelde C. The assessment of human health risks from rodent-borne diseases by means of ecological studies of rodent reservoirs. Mil Med 2002;167:70-3.
48. Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 2002;33:330-42.
49. Gubler DJ. Human arbovirus infections worldwide. Ann N Y Acad Sci 2001;951:13-24.
50. Meslin FX, Stohr K, Heymann D. Public health implications of emerging zoonoses. Rev Sci Tech 2000;19:310-7.
51. Byrd Jr. RP, Vasquez J, Roy TM. Respiratory manifestations of tick-borne diseases in southeastern United States. South Med J 1997;90:1-4.
52. Gentile DA. Tick-borne diseases. In: Auerbach PS, editor. wilderness medicine: management of wilderness and environmental emergencies. 3rd edition. St. Louis: Mosby; 1995. p. 787-812.
53. Calisher CH. Medically important arboviruses of the United States and Canada. Clin Microbiol Rev 1994;7:89-116.
54. Klasco R. Colorado tick fever. Med Clin North Am 2002;86:435-40.
55. Davis H, Vincent JM, Lynch J. Tick-borne relapsing fever caused by Borrelia turicatue. Pediatr Infect Dis J 2002;21:703-5.
56. Dworkin MS, Shoemaker PC, Fritz CL, Dowell ME, Anderson Jr. DE. The epidemiology of tick-borne relapsing fever in the United States. Am J Trop Med Hyg 2002;66:753-8.
57. Dworkin MS, Schwan TG, Anderson Jr DE. Tick-borne relapsing fever in North America. Med Clin North Am 2002;86:417-33.
58. Manufacturer discontinues only Lyme disease vaccine. FDA Consum 2002;36:5.
59. Gray J, von Stedingk LV, Granstrom M. Zoonotic babesiosis. Int J Med Microbiol 2002;291 (suppl): 108-11.
60. Dumler JS, Bakken JS. Human ehrlichioses: newly recognized infections transmitted by ticks. Annu Rev Med 1998;49:201-13.
61. Bakken JS. Human granulocytic ehrlichiosis in the United States. Infectious Med 1996;13: 877-8,883,887-9,912.
62. Mounzer KC, Dinubile MJ. Ehrlichial infections. Clin Dermatol 1996;14:289-93.
63. Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovick K, Dumler JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996;275:199-205.
64. Sjostedt A, Tarnvik A, Sandstrom G. Francisella tularensis: host-parasite interaction. FEMS Immunol Med Microbiol 1996;13:181-4.
65. Waag DM, Sandstrom G, England MJ, Williams JC. Immunogenicity of a new lot of Francisella tularensis live vaccine strain in human volunteers. FEMS Immunol Med Microbiol 1996;13: 205-9.
66. Stewart SJ. Tularemia: association with hunting and farming. FEMS Immunol Med Microbiol 1996;13:197-9.
67. Whitten P, Crowell RE, Levy H. Pulmonary and critical care pearls: shock in a patient exposed to rodents. Chest 1997;1126:1674-6.
68. Presutti RJ. Bite wounds: early treatment and prophylaxis against infectious complications. Postgrad Med 1997;101:243-54.
69. Smith JS. New aspects of rabies with emphasis on epidemiology, diagnosis, and prevention of the disease in the United States. Clin Microbiol 1996;9:166-76.
70. Geyer M, Van Leuven M, Murphy J, Damrow T, Sastry L, Miller S, et al. Human rabies - Montana and Washington, 1997. MMWR Morb Mortal Wkly Rep 1997;46:770-4.
71. Telford III SR. Risk for acquiring human granulocytic ehrlichiosis: exposure to deer blood or deer ticks? Clin Infect Dis 1997;24:531-2.